These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9155067)

  • 1. No association of a 306-bp insertion polymorphism in the progesterone receptor gene with ovarian and breast cancer.
    Manolitsas TP; Englefield P; Eccles DM; Campbell IG
    Br J Cancer; 1997; 75(9):1398-9. PubMed ID: 9155067
    [No Abstract]   [Full Text] [Related]  

  • 2. Ovarian carcinoma-associated TaqI restriction fragment length polymorphism in intron G of the progesterone receptor gene is due to an Alu sequence insertion.
    Rowe SM; Coughlan SJ; McKenna NJ; Garrett E; Kieback DG; Carney DN; Headon DR
    Cancer Res; 1995 Jul; 55(13):2743-5. PubMed ID: 7796397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two functionally relevant polymorphisms in the human progesterone receptor gene (+331 G/A and progins) and the predisposition for breast and/or ovarian cancer.
    Romano A; Lindsey PJ; Fischer DC; Delvoux B; Paulussen AD; Janssen RG; Kieback DG
    Gynecol Oncol; 2006 May; 101(2):287-95. PubMed ID: 16360811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone receptor gene polymorphism and risk for breast and ovarian cancer.
    Lancaster JM; Berchuck A; Carney ME; Wiseman R; Taylor JA
    Br J Cancer; 1998 Jul; 78(2):277. PubMed ID: 9683307
    [No Abstract]   [Full Text] [Related]  

  • 5. No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North Carolina.
    Lancaster JM; Wenham RM; Halabi S; Calingaert B; Marks JR; Moorman PG; Bentley RC; Berchuck A; Schildkraut JM
    Cancer Epidemiol Biomarkers Prev; 2003 Mar; 12(3):226-7. PubMed ID: 12646513
    [No Abstract]   [Full Text] [Related]  

  • 6. Worldwide distribution of allelic variation at the progesterone receptor locus and the incidence of female reproductive cancers.
    Rockwell LC; Rowe EJ; Arnson K; Jackson F; Froment A; Ndumbe P; Seck B; Jackson R; Lorenz JG
    Am J Hum Biol; 2012; 24(1):42-51. PubMed ID: 22121098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A germline variation in the progesterone receptor gene increases transcriptional activity and may modify ovarian cancer risk.
    Agoulnik IU; Tong XW; Fischer DC; Körner K; Atkinson NE; Edwards DP; Headon DR; Weigel NL; Kieback DG
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6340-7. PubMed ID: 15579801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No association between the progesterone receptor gene +331G/A polymorphism and breast cancer.
    Feigelson HS; Rodriguez C; Jacobs EJ; Diver WR; Thun MJ; Calle EE
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):1084-5. PubMed ID: 15184270
    [No Abstract]   [Full Text] [Related]  

  • 9. Analysis of the human progesterone receptor gene polymorphism progins in Austrian ovarian carcinoma patients.
    Tong D; Fabjani G; Heinze G; Obermair A; Leodolter S; Zeillinger R
    Int J Cancer; 2001 Nov; 95(6):394-7. PubMed ID: 11668524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the human progesterone receptor gene polymorphism PROGINS in Austrian ovarian cancer patients.
    Whittemore AS; McGuire V
    Int J Cancer; 2002 Sep; 101(2):202; author reply 203. PubMed ID: 12210000
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetics of endometriosis: a role for the progesterone receptor gene polymorphism PROGINS?
    Lattuada D; Somigliana E; Viganò P; Candiani M; Pardi G; Di Blasio AM
    Clin Endocrinol (Oxf); 2004 Aug; 61(2):190-4. PubMed ID: 15272913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A germline TaqI restriction fragment length polymorphism in the progesterone receptor gene in ovarian carcinoma.
    McKenna NJ; Kieback DG; Carney DN; Fanning M; McLinden J; Headon DR
    Br J Cancer; 1995 Mar; 71(3):451-5. PubMed ID: 7880723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis.
    Pearce CL; Hirschhorn JN; Wu AH; Burtt NP; Stram DO; Young S; Kolonel LN; Henderson BE; Altshuler D; Pike MC
    J Natl Cancer Inst; 2005 Jan; 97(1):51-9. PubMed ID: 15632380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of a progesterone receptor gene +331 G/A polymorphism with breast cancer risk: a meta-analysis.
    Yang DS; Sung HJ; Woo OH; Park KH; Woo SU; Kim AR; Lee ES; Lee JB; Kim YH; Kim JS; Seo JH
    Cancer Genet Cytogenet; 2010 Jan; 196(2):194-7. PubMed ID: 20082859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone receptor promoter +331A polymorphism is associated with a reduced risk of endometrioid and clear cell ovarian cancers.
    Berchuck A; Schildkraut JM; Wenham RM; Calingaert B; Ali S; Henriott A; Halabi S; Rodriguez GC; Gertig D; Purdie DM; Kelemen L; Spurdle AB; Marks J; Chenevix-Trench G
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2141-7. PubMed ID: 15598772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variation in the progesterone receptor gene and ovarian cancer risk.
    Terry KL; De Vivo I; Titus-Ernstoff L; Sluss PM; Cramer DW
    Am J Epidemiol; 2005 Mar; 161(5):442-51. PubMed ID: 15718480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 polymorphism in ovarian and breast cancer.
    Campbell IG; Eccles DM; Dunn B; Davis M; Leake V
    Lancet; 1996 Feb; 347(8998):393-4. PubMed ID: 8598715
    [No Abstract]   [Full Text] [Related]  

  • 18. No significant association between progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of ovarian cancer.
    Spurdle AB; Webb PM; Purdie DM; Chen X; Green A; Chenevix-Trench G
    Carcinogenesis; 2001 May; 22(5):717-21. PubMed ID: 11323389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progesterone receptor (PROGINS) polymorphism and the risk of ovarian cancer.
    Leite DB; Junqueira MG; de Carvalho CV; Massad-Costa AM; Gonçalves WJ; Nicolau SM; Lopes LA; Baracat EC; da Silva ID
    Steroids; 2008 Jul; 73(6):676-80. PubMed ID: 18384825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone receptor gene polymorphism is associated with decreased risk for breast cancer by age 50.
    Wang-Gohrke S; Chang-Claude J; Becher H; Kieback DG; Runnebaum IB
    Cancer Res; 2000 May; 60(9):2348-50. PubMed ID: 10811106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.